Mast Therapeutics Company Profile (NASDAQ:MSTX)

About Mast Therapeutics

Mast Therapeutics logoMast Therapeutics, Inc. is a biopharmaceutical company. The Company develops clinical-stage therapies for serious or life-threatening diseases with unmet needs. The Company focuses on developing new therapies for sickle cell disease, a chronic and genetic disorder classified as a rare, or orphan, disease in the United States of America and European Union, and for heart failure, a condition with an unmet need for treatment options. The Company's segment is engaged in the business of developing therapies for serious or life-threatening diseases. The Company focuses on its Molecular Adhesion and Sealant Technology (MAST) platform, to develop MST-188 (vepoloxamer) Injection, its lead product candidate. The Company also develops AIR001, a sodium nitrite solution for intermittent inhalation through nebulizer. The Company's AIR001 is in Phase II clinical development for the treatment of patients with HFpEF.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MSTX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.12
  • 50 Day Moving Average: $0.14
  • 200 Day Moving Average: $0.19
  • 52-Week Range: $0.07 - $0.71
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.00
  • P/E Growth: 0.00
  • Market Cap: $28.59M
  • Outstanding Shares: 238,230,000
Additional Links:

Analyst Ratings

Consensus Ratings for Mast Therapeutics (NASDAQ:MSTX) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Mast Therapeutics (NASDAQ:MSTX)
Show:
DateFirmActionRatingPrice TargetDetails
1/19/2017Canaccord GenuityReiterated RatingBuyView Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Mast Therapeutics (NASDAQ:MSTX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Mast Therapeutics (NASDAQ:MSTX)
Current Year EPS Consensus Estimate: $-0.20 EPS
Next Year EPS Consensus Estimate: $-0.12 EPS

Dividends

Dividend History for Mast Therapeutics (NASDAQ:MSTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mast Therapeutics (NASDAQ:MSTX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Mast Therapeutics (NASDAQ:MSTX)
DateHeadline
News IconBenjamin Watson: Protesting Against Education Sec. DeVos 'Hurts the Students' (NASDAQ:MSTX)
ekosvoice.com - February 15 at 1:45 AM
feeds.reuters.com logoBRIEF-Mast Therapeutics provides update on strategic direction (NASDAQ:MSTX)
feeds.reuters.com - November 21 at 9:03 AM
News IconInvesting Focus: Indicators in View on Shares of Mast Therapeutics Inc. (MSTX) - MicroCap Wired (NASDAQ:MSTX)
www.microcapwired.com - November 19 at 6:21 PM
News IconOverselling Stock in Spotlight: Mast Therapeutics Inc (NYSEMKT:MSTX) - Post Registrar (NASDAQ:MSTX)
postregistrar.com - November 17 at 10:05 AM
istreetwire.com logo3 Stocks in Focus: MannKind Corp. (MNKD), Mast Therapeutics, Inc. (MSTX), Level 3 Communications, Inc. (LVLT) - iStreetWire (NASDAQ:MSTX)
istreetwire.com - November 16 at 9:57 AM
News IconLookout for these Two stocks: Mast Therapeutics, Inc. (NYSEMKT:MSTX), The Blackstone Group L.P. (NYSE:BX) - The Newburgh Press (NASDAQ:MSTX)
newburghpress.com - November 16 at 9:57 AM
finance.yahoo.com logoMAST THERAPEUTICS, INC. Financials (NASDAQ:MSTX)
finance.yahoo.com - November 15 at 6:53 PM
marketexclusive.com logoMast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Reports Third Quarter 2016 Financial Results (NASDAQ:MSTX)
marketexclusive.com - November 10 at 6:01 PM
News IconShares to Watch: Indicator Update on Mast Therapeutics Inc. (MSTX) - MicroCap Wired (NASDAQ:MSTX)
www.microcapwired.com - November 9 at 6:09 PM
investopedia.com logoMast Therapeutics 3Q Loss Beats Street (MSTX) - Investopedia (NASDAQ:MSTX)
www.investopedia.com - November 9 at 6:09 PM
investopedia.com logoMast Therapeutics 3Q Loss 8.2M or 4c/Share (MSTX) (NASDAQ:MSTX)
www.investopedia.com - November 9 at 6:09 PM
istreetwire.com logoStocks Trend Analysis: Mast Therapeutics, Inc. (MSTX) Achillion Pharmaceuticals, Inc. (ACHN) EarthLink Holdings ... - iStreetWire (NASDAQ:MSTX)
istreetwire.com - November 8 at 9:31 AM
marketexclusive.com logoMast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Reports Third Quarter 2016 Financial Results - Market Exclusive (NASDAQ:MSTX)
marketexclusive.com - November 8 at 9:31 AM
sg.finance.yahoo.com logoMast reports 3Q loss (NASDAQ:MSTX)
sg.finance.yahoo.com - November 8 at 9:31 AM
biz.yahoo.com logoMAST THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (NASDAQ:MSTX)
biz.yahoo.com - November 8 at 9:31 AM
publicnow.com logoMast Therapeutics Reports Third Quarter 2016 Financial Results (NASDAQ:MSTX)
www.publicnow.com - November 8 at 9:31 AM
News IconMast Therapeutics touts interim data from pulmonary hypertension study (NASDAQ:MSTX)
www.massdevice.com - November 4 at 9:43 AM
News IconNewsmaking Penny Stock: Update on Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NASDAQ:MSTX)
www.duncanindependent.com - November 2 at 6:34 PM
prnewswire.com logoMast Therapeutics To Host Third Quarter 2016 Financial Results And Business Update Conference Call - PR Newswire (press release) (NASDAQ:MSTX)
www.prnewswire.com - November 2 at 9:50 AM
News IconMarket Rover: Looking at Levels on Shares of Mast Therapeutics Inc. (MSTX) - MicroCap Wired (NASDAQ:MSTX)
www.microcapwired.com - October 28 at 6:02 PM
News IconPenny Stock News: Checking in on Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NASDAQ:MSTX)
www.duncanindependent.com - October 28 at 6:02 PM
News IconWatching Technical Levels on Shares of Mast Therapeutics Inc. (MSTX) - MicroCap Wired (NASDAQ:MSTX)
www.microcapwired.com - October 27 at 6:21 PM
istreetwire.com logoThree Movers to Watch for: Mast Therapeutics, Inc. (MSTX), Atwood Oceanics, Inc. (ATW), Devon Energy Corporation ... - iStreetWire (NASDAQ:MSTX)
istreetwire.com - October 25 at 6:20 PM
News IconNewsmaking Penny Stock: Investors Checking Out Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NASDAQ:MSTX)
www.duncanindependent.com - October 25 at 6:20 PM
News IconPenny Stock Making a Splash, Zeroing in on Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NASDAQ:MSTX)
www.duncanindependent.com - October 20 at 6:36 PM
News IconMast Therapeutics (MSTX) Stock: Trending Up On New Agreement Announcement (NASDAQ:MSTX)
cnafinance.com - October 17 at 11:17 AM
News IconPenny Stock Investors Have a Keen Eye on Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NASDAQ:MSTX)
www.duncanindependent.com - October 14 at 6:02 PM
News IconActive Run Stocks Logging Brokers' Choice: Mast Therapeutics, Inc. (NYSE:MSTX), Fluidigm Corporation (NASDAQ ... - Street Wise Report (press release) (blog) (NASDAQ:MSTX)
streetwisereport.com - October 14 at 6:02 PM
News IconMover to Watch – Mast Therapeutics, Inc.'s (MSTX) | Hot Stocks Point - Hot Stocks Point (NASDAQ:MSTX)
www.hotstockspoint.com - October 14 at 6:02 PM
News IconCatching the Eye of Investors: Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NASDAQ:MSTX)
www.duncanindependent.com - October 7 at 6:02 PM
nasdaq.com logoMid-Day Market Update: Crude Oil Up 2.75%; Mast Therapeutics Shares Drop After Sickle Cell Drug Phase 3 Trial Fail - Nasdaq (NASDAQ:MSTX)
www.nasdaq.com - September 22 at 11:03 AM
smarteranalyst.com logoAnalysts Chime in on Two Collapsing Biotech Stocks: Mast Therapeutics Inc (MSTX) and Mirna Therapeutics Inc (MIRN) - Smarter Analyst (NASDAQ:MSTX)
www.smarteranalyst.com - September 22 at 11:03 AM
streetinsider.com logoMast Therapeutics (MSTX) Reports Vepoloxamer Phase 3 in Sickle Cell Missed Primary Endpoint (NASDAQ:MSTX)
www.streetinsider.com - September 21 at 10:23 AM
News IconMast Therapeutics (MSTX) Stock: EPIC Primary Endpoint Missed! (NASDAQ:MSTX)
cnafinance.com - September 21 at 10:23 AM
biz.yahoo.com logoMAST THERAPEUTICS, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligati (NASDAQ:MSTX)
biz.yahoo.com - September 21 at 10:23 AM

Social

What is Mast Therapeutics' stock symbol?

Mast Therapeutics trades on the NASDAQ under the ticker symbol "MSTX."

When will Mast Therapeutics announce their earnings?

Mast Therapeutics is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

How do I buy Mast Therapeutics stock?

Shares of Mast Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Mast Therapeutics stock cost?

One share of Mast Therapeutics stock can currently be purchased for approximately $0.12.

Mast Therapeutics (NASDAQ:MSTX) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Mast Therapeutics (NASDAQ:MSTX)

Earnings History Chart

Earnings by Quarter for Mast Therapeutics (NASDAQ:MSTX)

Dividend History Chart

Dividend Payments by Quarter for Mast Therapeutics (NASDAQ:MSTX)

Last Updated on 2/26/2017 by MarketBeat.com Staff